Shandong Xinhua Pharmaceutical.
0
00
统计数据
当日最高
-
当日最低
-
52周最高
-
52周最低
-
成交量
-
平均成交量
-
市值
-
市盈率
-
股息收益率
-
股息
-
即将到来
股息
NaN%股息收益率
10年增长
N/A
5年增长
N/A
3年增长
N/A
1年增长
25.04%
收益
30Oct预期
预期每股收益
N/A
实际每股收益
N/A
人们还关注
此列表基于关注SXPHF的Stock Events用户的观察列表。这不是投资建议。
竞争者
这个列表是基于最近市场事件的分析。这不是投资建议。
BeiGene
BGNE
市值21.34B
Zoomlion Heavy Industry Science and Technology
ZLIOY
市值7.14B
Sinopharm Group
SHTDY
市值7.28B
Santen Pharmaceutical.
SNPHY
市值4.38B
Johnson & Johnson
JNJ
市值399.26B
Pfizer
PFE
市值164.39B
Novartis
NVS
市值244.75B
GSK
GSK
市值89.55B
Merck
MRK
市值300.25B
关于
Health Technology
Pharmaceuticals: Other
Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally. The company offers antipyretic and analgesic drugs; cardiovascular and cerebrovascular drugs; anti-infective drugs and central nervous drugs; and other drugs. It engages in the development of real estate business. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.
Show more...
首席执行官
Mr. Tongqing He
员工
7064
国家
CN
ISIN
CNE100000411